Key result
Age, BMI, and hemoglobin influence walking distance more strongly in HFpEF than HFrEF.
Why the study?
Determinants of 6MWD may vary between HFrEF and HFpEF, and clarifying phenotype-specific factors could support personalized cardiac rehabilitation strategies.
What are the clinical determinants of six-minute walk distance in patients with HFrEF compared to HFpEF?
Meta-Analysis (n=4,931)
What are the clinical determinants of six-minute walk distance in patients with HFrEF compared to HFpEF?
Answers are grounded in this paper and cite their sources.
Determinants of functional capacity show distinct patterns between HFrEF and HFpEF, with systemic and metabolic factors like age, BMI, and hemoglobin having a stronger influence on exercise capacity in HFpEF.
Background The six-minute walk distance (6MWD) is a key indicator of functional capacity and prognosis in patients with heart failure (HF). However, its determinants may vary between HF with reduced (HFrEF) and preserved ejection fraction (HFpEF). Clarifying these phenotype-specific factors could support more personalized cardiac rehabilitation strategies. Purpose To identify and compare the determinants of 6MWD in HFrEF and HFpEF using subgroup meta-regression analysis. Methods This systematic review and meta-analysis was conducted in according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. PubMed, Web of Science, and Cochrane Library were systematically searched for studies comparing 6MWD between HFrEF and HFpEF. HF phenotypes were defined according to the EF criteria used in each study. Random-effects meta-regression analyses examined associations between 6MWD and clinical determinants (age, sex, BMI, diabetes, hemoglobin, EF, creatinine, pro-BNP, and β-blocker use), with interaction terms tested for phenotype-specific effects. Results Eleven studies including 4,931 patients (HFrEF: 3,262; HFpEF: 1,669) were analyzed. Higher age (HFrEF β = −4.03; HFpEF β = −7.52), BMI (HFrEF β = +0.71; HFpEF β = −7.59), and diabetes prevalence (HFrEF β = −3.53; HFpEF β = −2.80) were significantly associated with shorter 6MWD, whereas higher hemoglobin (HFrEF β = +29.0; HFpEF β = +189) and β-blocker use (HFrEF β = +1.27; HFpEF β = +2.18) were positively associated (all p < 0.001). EF was inversely related to 6MWD in HFrEF (β = −10.4, p < 0.001) but not in HFpEF. Interaction analyses revealed significantly stronger effects of age (β = −3.49, p < 0.001), BMI (β = −8.30, p < 0.001), and hemoglobin (β = +160, p = 0.004) in HFpEF. Conclusion Determinants of functional capacity showed both shared and distinct patterns between HFrEF and HFpEF. Across both phenotypes, higher age, diabetes prevalence, hemoglobin levels, and β-blocker use were significantly associated with 6MWD. The effects of age, BMI, hemoglobin, and β-blocker use were stronger in HFpEF, suggesting that systemic and metabolic background factors may influence exercise capacity in this phenotype. These findings support the need for phenotype-specific approaches in cardiac rehabilitation.
No takes yet. Share an insight, caveat, or question.
Ogura et al. (2026) conducted a meta-analysis in Heart failure (HFrEF and HFpEF) (n=4,931). Clinical determinants (age, BMI, hemoglobin, beta-blocker use) vs. HFrEF vs HFpEF was evaluated on Six-minute walk distance (6MWD) (p=<0.001). Clinical determinants of walking distance varied by phenotype, with age, BMI, and hemoglobin showing stronger effects in HFpEF than HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: